A

ADC Therapeutics SA
D

ADCT

1.97000
USD
-0.15
(-6.86%)
مغلق
حجم التداول
0
الربح لكل سهم
-2
العائد الربحي
-
P/E
-1
حجم السوق
190,478,545
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
    C
    CIEN
    1.630
    (1.90%)
    87.400 USD
    CSCO
    CSCO
    0.930
    (1.61%)
    58.530 USD
    DELL
    DELL
    3.840
    (3.43%)
    115.790 USD
    HPE
    HPE
    0.740
    (3.55%)
    21.610 USD
    HPQ
    HPQ
    0.485
    (1.49%)
    32.945 USD
    IBM
    IBM
    -0.540
    (-0.24%)
    223.370 USD
    I
    INFN
    0.04000
    (0.61%)
    6.60000 USD
    INTC
    INTC
    0.460
    (2.41%)
    19.530 USD
    J
    JNPR
    0.215
    (0.58%)
    37.220 USD
    NTAP
    NTAP
    1.910
    (1.64%)
    118.480 USD
    المزيد
الأخبار

العنوان: ADC Therapeutics SA

القطاع: Healthcare
الصناعة: Biotechnology
ADC Therapeutics SA is a commercial-stage oncology-focused biotechnology company. It is involved in the development of antibody-drug conjugates for patients suffering from hematological malignancies and solid tumors. The company's product candidate includes ZYNLONTA, camidanlumab tesirine, ADCT-602, ADCT-601, ADCT-901, ADCT-701 and ADCT-212.